A group of researchers at the University of Iowa has found that male fertility pills aren’t necessarily the cause of infertility, at least not according to a study published online this week in the Journal of the American Medical Association.
The study, led by lead author David Pomerantz, a professor of obstetrics and gynecology, found that even though male fertility products were not specifically identified as “male fertility treatments,” the pill-making process did lead to an increase in sperm counts in the testes of testicular cells.
The pill’s effects on sperm count were most pronounced in mice, and they were most marked in a subset of testes that are most prone to cancer, Pomeranz said.
The researchers then tried to test the effects of a variety of different male fertility treatments, including male condoms, male birth control pills, male contraceptive pills, and male birth management pills, he said.
They found that testosterone boosters, which are used to boost testosterone levels in men, did not seem to make any difference in sperm count, he told reporters at the time.
Instead, the pills they tested didn’t make any detectable difference in male fertility.
The researchers also found that sperm counts were increased in testes in male mice that had a male fertility pill, but not in mice that did not take testosterone boosters.
The pill-maker pill didn’t affect the sperm count in mice.
Male fertility treatments are widely prescribed for infertility treatment.
There are now more than 30,000 such products sold around the world.